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profile, due to greater urbanisation and the adoption of an 
unhealthy life style.(8) 
Another important contributor to the increase in CAD in this 
ethnic group may be related to the human immunodeficiency 
virus (HIV), as South Africa is the country with the highest 
number of HIV infections in the world.(9) It has been suggested 
that HIV infection per se should count as a coronary risk factor, 
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INTRODUCTION
Coronary Artery Disease (CAD) is a major cause of death and 
disability, worldwide. Similarly, in South Africa, which is a multi-
ethnic society with a large range of cultures and life styles, CAD 
is also a major cause of morbidity and mortality, particularly 
amongst the White and Indian populations.(1-3) In contrast, 
earlier studies found that CAD was relatively uncommon in the 
Black population, and this low incidence was suggested to be 
due to lower serum cholesterol and increased high-density 
lipoprotein (HDL) cholesterol levels.(4) In addition, assessment 
of selected risk factors for CAD in young South African male 
scholars by Seftel, et al. showed that both Indian and White 
scholars had a much higher prevalence and severity of CAD risk 
factors than Black youths.(5)
However, recently the INTERHEART Africa study reported 
that more premature acute myocardial infarctions (AMI) occur 
in sub-saharan Africa than in any of the other 52 countries 
participating in the INTERHEART study.(6,7) This is due largely 
to the modeling of 5 risk factors (smoking, diabetes, hyperten-
sion, abdominal obesity and dyslipidaemia), which provide a 
population attributable risk of 89.2% for AMI. These results are 
consistent with the overall INTERHEART Study. Of note is that 
the prevalence of CAD is also increasing in the South African 
Black population because they are exposed to a similar risk 
Objective: To assess various risk factors in Black South 
African patients presenting with acute myocardial 
infarction (AMI) to the Coronary Care Unit (CCU) at 
R.K. Khan Hospital, Durban, South Africa.
Methods and results: The study population was recruited 
from consecutive patients from a multi-ethnic back-
ground with a diagnosis of AMI over a 4 year period 
(2008 - 2012). Only patients who were of Black South 
African origin (n=94) were eligible for analysis. Demo-
graphic data stored in an electronic database were 
extracted from all patients. The mean age of the parti-
cipants was 54.3 ± 11.0 years of whom 85% were males. 
The majority presented with ST elevation myocardial 
infarction (STEMI) (83%) whilst 17% had Non ST eleva-
tion myocardial infarction (NSTEMI). Smoking (48%) 
and hypertension (46%) were the most commonly 
observed risk factors. Thirty six percent of patients 
developed one or more major adverse cardiac events 
(MACE). Recurrence of infarction and death occurred 
more frequently in females compared to males (14% vs. 
2%, p=0.04).
No signifi cant difference in MACE was found between 
patients who were human immunodefi ciency virus 
(HIV) positive (18%) compared to those who were HIV 
negative (82%). Metabolic syndrome, as defi ned by the 
International Diabetes Federation (IDF) criteria, was 
found in 35 (45%) of patients. The number of patients 
presenting with hypertension and diabetes was signifi -
cantly higher in our study compared to the INTER-
HEART Africa study (73% vs. 50%, p<0.01; and 40% vs. 
24%, p<0.01).
Conclusion: South African Blacks have multiple risk 
factors, similar to other ethnic groups in the country, 
which contribute to the development of AMI. Recur-
rence of infarction and death occurred more frequently 
in females compared to males. In addition to con-
ventional risk factors for CAD, an increased heart rate, 
STEMI, obesity, family history of cerebrovascular 
disease and hyperuricaemia are strongly associated 













similar to the traditional cardiovascular risk factors, since HIV 
infections may promote early atherosclerosis independently of 
these classical vascular risk factors.(10) 
The prevalence rate of the metabolic syndrome is also increasing 
in Black South Africans, which could be another factor con-
tributing to their increase in CAD.(11) Despite the growing 
burden of CAD in the Black population, there is still a paucity of 
information concerning the association between CAD and its 
known risk factors. The primary objective of this study, there-
fore, was to assess various risk factors in Black South African 
patients presenting with AMI to the Coronary Care Unit (CCU) 
at R.K. Khan Hospital, Durban.
METHODS
The study population was recruited from consecutive patients 
from a multi-ethnic background, with a diagnosis of AMI within 
24 hours of onset of symptoms to the CCU at R.K. Khan 
Hospital, Durban, over a four year period (2008 - 2012). Of the 
1 200 patients admitted with AMI, 87% were of Asian Indian 
origin, 7.8% Blacks, 4.4% Whites, and 0.8% Coloureds. Only 
patients of South African Black origin (n=94) were eligible for 
analysis. The study was carried out according to the principles 
of the Declaration of Helsinki and was approved by the local 
ethics committee. Acute myocardial infarction was defined by 
prolonged chest discomfort, typical electrocardiographic (ECG) 
changes, and elevated cardiac troponin T (cTnT) levels as 
outlined by the Joint European Society of Cardiology/American 
College of Cardiology Committee.(12)
Clinical assessment
Demographic data stored in an electronic database were 
extracted for all eligible patients. Every patient underwent an 
initial assessment that included clinical history, physical exami-
nation, and 12-lead surface ECG. Current smokers were defined 
as those individuals who had smoked any tobacco in the 
previous 12 months, and former smokers as those who had not 
smoked for a period of at least a year. A family history of 
premature atherosclerosis was defined by a history of myo-
cardial infarction in either parents, or in siblings, or first degree 
relatives at the age of 55 years or younger, for males, and 65 
years or younger, in females, whilst a family history of diabetes, 
hypertension, and cerebrovascular disease was defined as these 
conditions occurring at any age. Additional clinical data included 
a detailed description of major adverse cardiac events (MACE) 
encountered during hospital admission until 6 months follow-
up, such as ventricular arrhythmias, complete heart block, 
cardiac failure, cardiogenic shock, recurrence of angina or 
myocardial infarction and death.
In keeping with standard acute coronary syndrome guidelines, 
all patients were counseled and offered coronary angiograms, 
which were performed at another referral hospital. Patients 
were required to consent to both coronary angiography and 
cardiac revascularisation procedures such as percutaneous 
coronary intervention (PCI) and coronary artery bypass grafting 
(CABG), should there be a need to perform these procedures. 
This type of triage is necessary due to the large volume of work 
and the lack of adequate facilities in the public sector (only 1 
government-based hospital in the province of KwaZulu-Natal 
offers these specialised facilities). Consequently, only a limited 
number of patients underwent coronary angiography because 
the majority declined cardiac revascularisation. Patients who 
were eligible were thrombolysed with metalyse as a reperfusion 
therapy. 
Since the INTERHEART Africa Study is probably the most 
comprehensive case-control study conducted among patients 
with AMI in sub-saharan Africa (SSA), we also explored the 
association of known cardiovascular risk factors and AMI 
between the Black African group of this study (n=144) and our 
study population.
Anthropometric measurements
The body mass index (BMI) was calculated as weight (kilograms) 
divided by height2 (meters) according to the World Health 
Organisation guidelines.(13) 
A BMI≥30kg/m2 was used to define adult obesity. Waist cir-
cumference, which is considered the most practical way to 
assess central obesity, was measured midway between the 
lowest rib and the iliac crest on standing subjects, using a soft 
tape. The presence of the metabolic syndrome, as outlined by 
the International Diabetes Federation (IDF), was defined as 
central obesity (waist circumference: males ≥94cm, females 
≥80cm) plus any 2 of the criteria shown in Table 2.(14)  
Biochemical Analyses
Blood samples for routine biochemistry were collected from all 
subjects on hospital admission and carried out using standard 
methods. Troponin T measured on the Elecsys 2010 (Roche 
Diagnostics) was considered positive at a cut-off value greater 
than 0.03ng/ml. Blood samples were also collected within 48 
hours of admission after an overnight fast for total cholesterol, 
triglycerides and HDL cholesterol, which were measured on 
the Beckman Synchron CX7 auto analyser. Low-density lipo-
protein (LDL) cholesterol levels were calculated utilising the 
formula of Friedewald. The HIV status of every patient was 
determined using the Enzyme linked immunosorbent assay 
(ELISA).
Statistical analyses
Data were processed and analysed using Stata 13.0 (StataCorp. 
2013. Stata Statistical Software: Release 13. College Station, TX: 
StataCorp LP). Differences in means of continuous variables 
by dichotomous classification (e.g. gender, HIV status and 
adverse cardiac events) were assessed using t-tests (or the 
non-para-metric equivalent, namely the Wilcoxon Rank Sum 
Test). Differences in frequencies of categorical demographic 
variable by metabolic syndrome status and other categorical 
outcomes were assessed using the Pearson chi-square (χ2) 
test. If an expected cell count has fewer than 5 observations, 
then the Fishers Exact Test P-values are presented instead. 
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Bivariate and multivariable logistic regression was employed to 
estimate the association between clinical and laboratory para-
meters and MACE. Coefficients were exponentiated to repre-
sent odds ratios (ORs) and 95% confidence intervals. An 
adjusted P-value of <0.05 was deemed statistically significant.
RESULTS
Of the 94 patients in the study cohort, 58 (85%) were males. 
The mean age of the study population was 54.3 ± 11.0 years, 
with the majority presenting with ST elevation myocardial 
infarction (STEMI) (83%), whilst 17% had Non ST elevation 
myocardial infarction (NSTEMI) (Table 1). Previous and current 
smoking (48%) and hypertension (46%) were the most com-
monly observed risk factors. A significantly greater number of 
men had a history of smoking compared to their female 
counterparts [72% vs. 8%, OR 28.87 (95% CI 7.75 - 107.52); 
p<0.01], while females in contrast were found to have a higher 
incidence of hypertension [67% vs. 33%, OR 0.24 (95% CI 
0.1 - 0.59); p<0.01]. Although haemoglobin levels were signi-
ficantly lower in female patients (12.38 ± 1.91g/dl vs. 14.06 ± 
1.9g/dl, p<0.01), male patients had higher creatinine values 
(101.24 ± 27.85umol/L vs. 83.08 ± 21.3umol/L, p<0.01).
From index hospitalisation until 6-month follow-up, 36% of 
patients developed one or more MACE. Recurrence of infarc-
tion and death occurred more frequently in females compared 
to males [14% vs. 2%, OR 0.11 (95% CI 0.01 - 0.97); p=0.04]. 
No significant difference was found in traditional cardiovascular 
risk factors and MACE between patients who were HIV positive 
(18%) compared to those who were HIV negative (82%, data 
not shown). Only 23 patients had coronary angiograms per-
formed at another referral hospital because most patients 
declined coronary revascularisation. Thirty five percent pre-
sented with triple vessel disease, 22% with double vessel, and 
26% with single vessel disease while 17% had normal coronary 
angiograms. 
Metabolic syndrome, as defined by the IDF criteria, was found 
in 35 (45%) of the study population (Table 2). Central obesity 
was the major IDF determinant in patients with or without the 
metabolic syndrome (100% vs. 61%, p<0.01), while elevated 
blood pressure (83%), low HDL cholesterol levels (80%), raised 
triglyceride (48%), and fasting blood glucose values (46%) 
occurred significantly more frequently in patients with the 
metabolic syndrome.
Table 3 compares the risk profile for AMI between the Black 
population of the INTERHEART Africa study and the R.K. Khan 
Hospital study. The number of patients presenting with hyper-
tension and diabetes was significantly higher in our study com-
pared to the INTERHEART Africa study (73% vs. 50%, p<0.01; 
and 40% vs. 24%, p<0.01), respectively. The lipid profiles were 
similar for the 2 study groups.
Figure 1 illustrates the presence of various combinations of any 
6 risk factors for AMI, namely diabetes, smoking, family history 
of vascular disease, dyslipidaemia, hypertension and central 
obesity. Of note is that 32% of patients had 4 risk factors, 20% 
presented with 5 risk factors, and overall 89% had 2 or more 
risk factors for AMI. 
A multivariable analysis for factors associated with MACE by 
logistic regression was done (Table 4). After multivariable 
adjustment, an increased heart rate (>100 beats per minute) 
(OR 1.06 [95% CI 1.01 - 1.10]; p=0.01), STEMI (OR 5.89 [95% 
CI 1.22 - 28.51]; p=0.03), obesity (OR 3.86 [95% CI 1.18 - 
12.63]; p=0.03), a family history of cerebrovascular disease (OR 
14.83 [95% CI 1.10 - 200.82]; p=0.04) and hyperuricaemia (OR 
3.64 [95% CI 1.05 - 12.66]; p=0.04) was significantly associated 
with MACE.
DISCUSSION
In this study, South African Black patients were characterised 
by the presence of multiple risk factors for AMI. Previous and 
current smoking (48%), hypertension (46%), and diabetes (40%) 
were the most commonly observed risk factors. Of note is 
that 89% of patients had 2 or more risk factors for AMI, with 
32% presenting with 4 risk factors while 20% had 5 risk factors. 
These results are consistent with the INTERHEART Africa 
Study and confirm that people from Africa, particularly Black 
South Africans who, when exposed to known major CAD risk 
factors, are at risk to develop AMI, as are people across the 
globe.(15)
Furthermore, our data show that patients in the R.K. Khan 
Hospital study had a significantly higher prevalence of hyper-
tension (p<0.01) and diabetes (p<0.01) compared to the Black 
patients in the INTERHEART Africa study. These results assume 
greater importance since it was reported that a history of 
hypertension was significantly stronger in the total African 
population compared to the global INTERHEART population 
(p=0.002 for tests of heterogeneity of effects).(6) What was 
once considered a rare disease in this ethnic group,(16,17) is now 
observed more frequently, suggesting that uncontrolled major 
CAD risk factors will have a larger impact on the burden of 
CAD in Africa than elsewhere. This is supported by the fact 
that although only 25% of patients in the study cohort under-
went cardiac catheterisation studies, most patients presented 
with advanced triple vessel disease (35%), with 17% having 
normal coronary angiograms. In addition, 36% of subjects 
experienced MACE during the study follow-up period, with 
recurrence of myocardial infarction (p=0.04) and death 
(p=0.04) occurring more often in females compared to their 
male counterparts. 
Several studies have reported an association between HIV 
disease and CAD, which may occur because of dyslipidaemia, 
glucose intolerance and endothelial dysfunction secondary to 
some antiretroviral drugs.(18,19) This is of particular importance in 
the South African setting, since it is the country with the highest 
number of HIV infections in the world.(9)  Eighteen percent of 



















Males vs. Females P-value
STEMI 83 85 81
1.31 (0.44 - 3.91) 0.62
NSTEMI 17 15 19
Body mass index
Normal (≤25kg/m2) 26 38 6 10.39 (2.27 - 47.57) <0.01
Pre-obese (26 - 29kg/m2) 35 36 33 1.14 (0.47 - 2.73) 0.78
Obese (≥30kg/m2) 31 24 42 0.45 (0.18 - 1.09) 0.08
Risk Factors
Previous and current smoking 48 72 8 28.87 (7.75 - 107.52) <0.01
Hypertension 46 33 67 0.24 (0.1 - 0.59) <0.01
Diabetes 40 33 53 0.44 (0.19 - 1.02) 0.06
Previous angina 5 5 6 0.93 (0.15 - 5.84) 0.94
Previous myocardial infarction 4 5 3 1.91 (0.19 - 19.09) 0.58
Family History of vascular disease
Hypertension 18 16 22 0.64 (0.22 - 1.85) 0.41
Diabetes 17 12 25 0.41 (0.14 - 1.23) 0.11
Coronary Artery disease 9 7 11 0.59 (0.14 - 2.53) 0.48
Cerebrovascular disease 5 4 8 0.39 (0.06 - 2.47) 0.32
Continuous variables Mean (SD) Mean (SD) Mean (SD) OR (95% CI)Males vs. Females P-value
Age (years) 54.3 (11.0) 53.02 (9.9) 56.31(12.37) 0.97 (0.93 - 1.01) 0.16
Systolic blood pressure (mmHg) 142.29 (29.04) 138.03 (26.4) 149.14 (32.05) 0.99 (0.97 - 1.0) 0.08
Diastolic blood pressure (mmHg) 88.33 (20.56) 87.31 (19.01) 89.97 (23.04) 0.99 (0.97 - 1.01) 0.54
Abdominal girth (cm) 99.88 (13.5) 97.98 (14.27) 102.94 (11.72) 0.97 (0.94 - 1.01) 0.11
Biochemical Data
Haemoglobin (g/dl) 13.42 (2.06) 14.06 (1.9) 12.38 (1.91) 1.66 (1.25 - 2.2) <0.01
Blood glucose (mmol/L) 8.87 (5.76) 8.22 (5.11) 9.92 (6.61) 0.95 (0.88 - 1.02) 0.17
Creatinine (umol/L) 94.29 (26.96) 101.24 (27.85) 83.08 (21.3) 1.04 (1.01 - 1.07) <0.01
Uric acid (mmol/L) 0.39 (0.13) 0.39 (0.14) 0.39 (0.12) 1.03 (0.04 - 25.96) 0.99
Total cholesterol (mmol/L) 4.8 (1.74) 4.77 (1.86) 4.85 (1.54) 0.97 (0.77 - 1.23) 0.82
LDL cholesterol (mmol/L) 3.20 (1.12) 2.9 (1.01) 3.22 (1.28) 0.77 (0.52 - 1.15) 0.20
HDL cholesterol (mmol/L) 1.30 (0.35) 1.01 (0.34) 1.05 (0.37) 0.71 (0.21 - 2.41) 0.58
Triglycerides (mmol/L) 1.48 (1.41) 1.58 (1.63) 1.32 (0.97) 1.17 (0.81 - 1.69) 0.40
MACE 36 31 44 0.56 (0.24 - 1.33) 0.19
Cardiac failure 18 14 25 0.48 (0.17 - 1.39) 0.18
Death 6 2 14 0.11 (0.01 - 0.97) 0.04
Recurrence of infarction 6 2 14 0.11 (0.01 - 0.97) 0.04
Ventricular arrhythmia 6 9 3 3.3 (0.37 - 29.48) 0.29
Atrial fi brillation 4 3 6 0.61 (0.08 - 4.51) 0.63
Cardiogenic shock 4 5 3 1.91 (0.19 - 19.09) 0.58
Recurrence of angina 3 2 6 0.3 (0.03 - 3.41) 0.33
Cerebrovascular accident 3 3 3 1.25 (0.11 - 14.3) 0.86
Heart block 2 3 0 NC 0.52
Medication at discharge
Nitrates 100 100 100 NC
Disprin 100 100 100 NC
Statins 94 93 94 0.79 (0.14 - 4.57) 0.80
ACEI/ARB 89 86 94 0.37 (0.07 - 1.84) 0.22
Beta blockers 56 55 58 0.88 (0.38 - 2.04) 0.76
Calcium antagonist 6 5 8 0.60 (0.11 - 3.15) 0.55
Coronary Angiogram n=23 n=14 n=9
1.61 (0.35 - 4.48) 0.54
Single vessel disease 26 21 33
Double vessel disease 22 29 11
Triple vessel disease 35 36 33
CABG 17 14 22 0.58 (0.07 - 5.11) 0.63
PCI 0 0 0 NC
TABLE 1: Baseline characteristics and gender differences.
MACE = Major Adverse Cardiac Events, NC = Not Calculated.
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were on highly active antiretroviral therapy (HAART). This 
presented us with the unique opportunity of studying a 
HAART- naïve population, thus negating the potential effects of 
HAART on thrombotic risk. Consistent with the study by 
Becker, et al.(20) our treatment-naïve HIV positive patients with 
AMI presented at a young age and had a high prevalence of 
smoking. In contrast, however, we did not find any significant 
difference in traditional cardiovascular risk factors between HIV 
positive and HIV negative patients. In addition, we found no 
significant difference in MACE between the 2 groups.
The metabolic syndrome contributes to an increased risk of 
cardiovascular disease.(21) Many of the metabolic abnormalities 
common to this syndrome such as insulin resistance, central 
obesity, dyslipidaemia and hypertension are all independent risk 
factors for the development of cardiovascular disease, which 
when grouped together, amplify this risk. It is also well 
recognised that the incidence of the metabolic syndrome varies 
among different ethnic groups.(22) The prevalence of the meta-
bolic syndrome in Asian Indians presenting with AMI to the 
CCU at R.K. Khan Hospital was reported to be 57% according 
to the IDF criteria.(23) 
Similarly, in Black patients with AMI, the metabolic syndrome 
was seen in 45% of the study population based on the IDF 
definition. These results concur with another study amongst 
South African Blacks with CAD in whom the metabolic syn-
drome was found to be highly prevalent (60%).(11) The metabolic 
syndrome, therefore, may be another factor contributing to 
the increase in AMI in the Black population.
More importantly, following multivariable analysis using logistic 
regression, our data showed that several clinical and labora-
tory parameters are significantly associated with MACE such as 
an increased heart rate (p=0.01), STEMI (p=0.03), obesity 
(p=0.03), a family history of cerebrovascular disease (p=0.04) 
and hyperuricaemia (p=0.04).
Characteristics INTERHEART Africa % (n=144)
R. K. Khan
% (n=94) OR (95% CI) P-value
Male 64 62 0.91 (0.51 - 1.62) 0.73
Hypertension 50 73 2.76 (1.52 - 5.06) <0.01
Diabetes 24 40 2.11 (1.16 - 3.85) <0.01
Smoker (current/former) 45 48 1.12 (0.64 - 1.94) 0.68
Continuous variables Mean (SD) Mean (SD) P-value
Age 52.3 (12.3) 54.3 (11.0) 0.20
Total cholesterol 4.50 (1.18) 4.80 (1.74) 0.11
HDL cholesterol 0.99 (0.45) 1.03 (0.35) 0.46
LDL cholesterol 2.83 (0.97) 3.02 (1.12) 0.16
BMI 28.4 (5.2) 28.1 (5.9) 0.68




Patients with Metabolic 
Syndrome % (n=35)
Patients without 




(male ≥94cm, females ≥80cm)
78 100 61 <0.01
Fasting glucose
 ≥5.6mmol/L*
26 46 11 <0.01
Triglycerides
 >1.7mmol/L




63 80 50 0.01
Blood pressure 
(≥130/≥85mmHg)*
52 83 28 <0.01
TABLE 2: Prevalence of the metabolic syndrome according to the IDF definition and frequency of individual criteria. 














Potential limitations of this study merit consideration. Firstly, 
because of the relatively small sample size, results for smaller 
subgroups should be interpreted with caution. Secondly, this 
was a single centre study and selection bias might exist. Finally, 
not all patients were subjected to cardiac catheterisation studies 
and data on angiographic severity of CAD and cardiac revas-
cularisation was, therefore, tentative.
CONCLUSION
This study demonstrates that South African Blacks have multiple 
risk factors, similar to other ethnic groups in the country, which 
contribute to the development of AMI. In addition to con-
ventional risk factors for CAD, an increased heart rate, STEMI, 
obesity, a family history of cerebrovascular disease and 
hyperuricarmia are strongly associated with the presence of 
MACE. Furthermore, recurrence of infarction and death 
occurred more frequently in females compared to males. These 
results highlight the urgent need for lifestyle modification and 
effective treatment of CAD risk factors, particularly in the Black 
population.
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Characteristics BivariateOR (95% CI) P-value
Multivariable
OR (95% CI) P-value
Age 1.03 (0.99 - 1.08) 0.11 1.02 (0.96 - 1.08) 0.55
Male 0.56 (0.24 - 1.33) 0.19 0.72 (0.14 - 3.56) 0.68
Heart rate 1.03 (1.01 - 1.06) 0.02 1.06 (1.01 - 1.10) 0.01
HIV positive 0.69 (0.22 - 2.16) 0.52 0.65 (0.13 - 3.15) 0.59
STEMI vs. NSTEMI 2.0 (0.67 - 5.93) 0.21 5.98 (1.22 - 28.51) 0.03
Diabetes 1.54 (0.65 - 3.61) 0.33 1.03 (0.27 - 3.89) 0.97
Hypertension 1.01 (0.39 - 2.62) 0.98 0.95 (0.23 - 3.93) 0.95
Smoking 0.54 (0.23 - 1.28) 0.16 0.60 (0.13 - 2.78) 0.51
Obesity 1.05 (0.43 - 2.56) 0.92 3.86 (1.18 - 12.63) 0.03
Family history of cerebrovascular disease 7.87 (0.84 - 73.52) 0.07 14.83 (1.10 - 200.82) 0.04
Metabolic syndrome 0.86 (0.34 - 2.19) 0.75 0.66 (0.18 - 2.43) 0.53
Creatinine 1.02 (1.0 - 1.04) 0.04 1.02 (0.99 -1.04) 0.13
Blood glucose 1.06 (0.99 - 1.14) 0.11 1.0 (0.88 -1.12) 0.94
Uric acid 2.53 (1.05 - 6.07) 0.04 3.64 (1.05 -12.66) 0.04
Triglycerides 0.86 (0.59 - 1.25) 0.42 0.82 (0.48 - 1.40) 0.47
 
TABLE 4: Bivariate and multivariate logistic regression analysis of clinical and laboratory parameters associated with MACE.
FIGURE 1: Proportion of acute myocardial infarction 
patients with various combinations of risk factors.
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